-
Study aim
-
Determining the effect of 78% dark chocolate on depression (primary outcome) and sleep quality and anthropometric indicators among postmenopausal women (secondary outcomes).
-
Design
-
A double-blind randomized controlled clinical trial, 60 postmenopausal women will be assigned to one of the intervention and control groups with a ratio of 1:1, using a computerized random number table and through blocks of six.
-
Settings and conduct
-
People will be selected from the health centers of Tabriz, Al-Zahra and Taleghani hospitals. The list of people will be extracted from the Sib system first. The chocolates of both groups will be presented in the same shape and size and similar packages. Due to the difference in the taste of dark and milk chocolate, the outcome evaluation will be blind and a person who was not involved in the sampling will be asked. to check the results at the end of the intervention.
-
Participants/Inclusion and exclusion criteria
-
Entry requirements: age 45-65, menopause, having depression, desire to consume chocolate and not allergic to cocoa and any of the components of chocolate.
Conditions of non-entry: cardiovascular, digestive, liver or kidney diseases, diabetes mellitus, high blood pressure under treatment, fibrocystic breast problems, dyslipidemia, neurological or neuropsychological diseases, depression under treatment, hormone therapy, habit of daily consumption of cocoa or coffee products. Habitual use of invigorating teas.
-
Intervention groups
-
Participants in the intervention group will receive 12 grams of 78% dark chocolate and participants in the control group will receive 12 grams of milk chocolate daily for 8 weeks. The cocoa content of milk chocolates will be less than 2%.
-
Main outcome variables
-
Comparison of the average score of depression in the two groups receiving dark chocolate and the control group after the end of the intervention